Kathrin Nikolussi is a 2x Olympian who has spent the last 15 years building personalized wellness companies. She’s held executive positions with some of the pioneers in the testing & supplement space, including WellnessFX and Thorne Health Tech where she was their Chief Business Officer for six years. She also shares a deep concern for the drastic worldwide decline in fertility and the contributing environmental toxins and chemicals in our food chain. Her mission is to transform our wellness space by helping consumers cut through the noise to find relevant products that are scientifically valid and evidence based.

Craig Lipset leads at the forefront of innovation in clinical research and medicine development. Craig was the Head of Clinical Innovation and Venture Partner at Pfizer, on the founding Operations Committee for TransCelerate Biopharma, and on the founding management teams for two successful startup ventures (Perceptive Informatics and Adnexus Therapeutics). During that time, Craig designed and launched multiple industry firsts -- from the first fully remote/virtual clinical trial for a new medicine to the first returning of results and data to research participants.

Melinda Decker is a passionate leader with a rare mix of both commercial and R&D expertise, developed over nearly 20 years in the pharmaceutical-biotech industry. She has broad therapeutic experience with biologic, small molecule and digital health products, across both specialty and primary care, and with both global and local markets. She currently is the Oncology TA Head for Intelligent Pharmaceuticals, AstraZeneca’s digital therapeutics team, focused on improving patient outcomes through digital health.